FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.
For more information on lot numbers and product descriptions, see the FDA release:www.fda.gov/Safety/Recalls/ucm469980.htm



More Latest News

FDA meeting on September 20-21, 2016
September 23, 2016

On September 20-21, 2016 Allison Dudley, Executive Director and David Flynn, Counsel to the Board attended an inter-governmental working meeting at the Food and Drug Administration to discuss the oversight of drug compounding and the relationship between the activities of … Continue reading


Board Chairs, Vice Chairs & Associations’ Meeting Announcement
September 9, 2016

The Florida Department of Health, Division of Medical Quality Assurance (MQA) announces the following meetings: Continue reading